Your browser doesn't support javascript.
loading
Estrogen Sulfotransferase SULT1E1 Expression Levels and Regulated Factors in Malignant Tumours.
Wang, Rui; Li, Xia; Li, Yangyang; Zhao, Mengjie; Mi, Lida; Chen, Weiwei; Song, Jianxiang.
Affiliation
  • Wang R; Department of Thoracic Surgery, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, Yancheng 224000, PR China.
  • Li X; Medical School of Nantong University, Nantong, 226007, PR China.
  • Li Y; Department of General Medicine, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, Yancheng 224000, PR China.
  • Zhao M; Department of Thoracic Surgery, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, Yancheng 224000, PR China.
  • Mi L; Department of Thoracic Surgery, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, Yancheng 224000, PR China.
  • Chen W; Department of Thoracic Surgery, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, Yancheng 224000, PR China.
  • Song J; Department of Radiotherapy, The Sixth Affiliated Hospital of Nantong University, Yancheng Third People's Hospital, Yancheng 224000, PR China.
Protein Pept Lett ; 30(10): 821-829, 2023.
Article in En | MEDLINE | ID: mdl-37724676
ABSTRACT
Estrogen plays a key role in the development and progression of many malignant tumours, and the regulation of estrogen levels involves several metabolic pathways. Among these pathways, estrogen sulfotransferase (SULT1E1) is the enzyme with the most affinity for estrogen and is primarily responsible for catalysing the metabolic reaction of estrogen sulphation. Relevant studies have shown significant differences in the expression of SULT1E1 in different malignant tumours, suggesting that SULT1E1 plays a dual role in malignant tumours, both inhibiting the growth of malignant tumours and promoting their development. In addition, the expression level of SULT1E1 may be regulated by a variety of factors, which in turn affect the growth and therapeutic effects of malignant tumours. The aim of this paper is to review the mechanism of action of SULT1E1 in malignant tumours and the mechanisms that are regulated, in order to provide potential targets for the treatment of malignant tumour patients in the future and theoretical support for the realisation of more personalised and effective therapeutic regimens.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Estrogens / Neoplasms Limits: Humans Language: En Journal: Protein Pept Lett Journal subject: BIOQUIMICA Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Estrogens / Neoplasms Limits: Humans Language: En Journal: Protein Pept Lett Journal subject: BIOQUIMICA Year: 2023 Type: Article